x

Phenotypically relevant human disease models designed for you

Human iPSC disease models recapitulate the profile of human diseases in vitro, providing a physiologically relevant model for the study of pathophysiological mechanisms and for safety and efficacy screening of compounds. Ncardia’s expertise and in-house capabilities facilitate the efficient generation of clinically relevant custom disease models based on iPSC technology.

 

Contact us
Schematic overview of Ncardia's iPSC sourcing and reprogramming process

Patient-derived, genome-edited and induced disease models

Human iPSC technology is an excellent tool to improve decision-making steps throughout the early stages of drug discovery. The main benefits of using human iPSC in disease modeling are that they retain patient-specific genetic backgrounds, can be genetically engineered and closely mimic human pathophysiology.

Disease modeling based on human iPSC-derived cells has the potential to revolutionize drug discovery. Nonetheless, significant expertise is required to overcome some technical and conceptual difficulties for the widespread implementation of these models in the pharmaceutical and biotechnology industry.

Partnering with a company that has expertise in human iPSC technology, can help fully leverage its advantages.

Solutions

Ncardia has more than 10 years of experience with human iPSCs, in-house state-of-the-art technology and a highly qualified team to guide and assist you along the steps of disease modeling in any therapeutic area.

Click on each of the steps to discover how we can support you:

Cells in dish icon

Sourcing, reprogramming and genome editing

Gene editing icon

Large-scale differentiation

Differentiation icon

Phenotypic screening

Work with your own iPSC lines, our proprietary lines or we assist you sourcing the perfect line for your project

Ncardia offers sourcing of healthy and disease human iPSC lines through established relationships with leading medical centers and consortia. Appropriate ethical approvals, consents, and contracts are in place, so that human iPSC lines from a wide variety of genetic diseases can be acquired on demand.

In-house reprogramming can be performed when requested. We utilize non-integrating methods like Sendai virus or episomal reprogramming.

CRISPR is a highly efficient genome editing tool that can be applied to your human iPSC line of choice. Using this technology, disease models can be derived from healthy human iPSC lines via knock-in, knock-out, or introduction of point mutations. Mutations present in patient-derived iPSC lines can be corrected with the same approach to generate isogenic controls avoiding background-related variability in the screenings.

> Learn more

Choose your desired functional cell type and we adapt the scale to your requirements

Ncardia has established high-quality and reproducible differentiation protocols for a wide range of cell lineages. Generated iPSC lines can be manufactured at large-scale, to minimize variability and enhance assay reproducibility.

> Learn more

 

Fully characterized human iPSC-derived disease models based on clinically relevant readouts

Ncardia develop high-quality assays that are reproducible, predictive, and available for screening at high- and low-throughput. Our scientists define the optimal conditions for each assay and ensure the selection of the most suitable readouts to characterize your disease phenotype.

> Learn more

Explore our Resources

Ncardia’s team has the experience and knowledge needed to successfully generate models for cardiovascular, neurodegenerative, musculoskeletal, and immune diseases and to continuously expand into additional therapeutic areas.